Abnormal Granulocytopoietic Cell Morphology C4023031
An abnormality in the appearance of cells that develop into granulocytes in the bone marrow. This can affect blood cell production. Evaluation and treatment address the underlying cause.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Fever
Elevated body temperature often accompanied by chills and sweating.
Seek immediate care if fever exceeds 101°F (38.3°C) or is accompanied by confusion, rapid breathing, or severe weakness.
Frequent Infections
Recurrent bacterial, viral, or fungal infections due to impaired granulocyte function.
Seek urgent care if experiencing signs of serious infection such as high fever, difficulty breathing, or confusion.
Fatigue
(constitutional)Persistent tiredness and lack of energy that interferes with daily activities.
Frequency: 70-80% of patients
Easy Bruising
(dermatologic)Bruises appearing with minimal trauma due to altered blood cell morphology.
Frequency: 40-50% of patients
Bone Pain
(musculoskeletal)Deep aching pain in bones, often in the back, hips, or legs.
Frequency: 35-45% of patients
Pallor
(dermatologic)Unusually pale skin due to reduced blood cell production in the bone marrow.
Frequency: 30-40% of patients
Shortness of Breath
(respiratory)Difficulty breathing or feeling breathless with minimal exertion.
Frequency: 25-35% of patients
Night Sweats
(constitutional)Excessive sweating during sleep that may soak bedding and clothing.
Frequency: 15-20% of patients
Unintentional Weight Loss
(constitutional)Significant weight loss without changes in diet or exercise.
Frequency: 10-15% of patients
Lymphadenopathy
(lymphatic)Enlarged lymph nodes in the neck, armpits, or groin.
Frequency: 10-15% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Peripheral blood smear review
Regular microscopic examination of blood cells to assess morphology changes and monitor for progression or improvement.
Flow cytometry analysis
Advanced laboratory technique to characterize cell populations and identify abnormal cell markers contributing to morphology changes.
Additional treatment options
Growth factor therapy
Pharmacologic agents that support normal maturation and morphology of blood cell precursors in the bone marrow.
medicationStress reduction techniques
Mind-body interventions such as meditation and relaxation exercises that may support overall hematopoietic function.
complementaryBone marrow examination
Definitive diagnostic procedure to directly assess bone marrow cell morphology and identify primary hematologic disorders.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Granulocytopoietic Cell Morphology C4023031?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th Edition. International Agency for Research on Cancer, Lyon, France.
Hoffbrand AV, Higgs DR, Keeling DM, Mehta AB. Postgraduate Haematology, 7th Edition. Wiley-Blackwell.
Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Edition. IARC Press.
Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia. Blood. 2009;114(5):937-951.
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405.
Bain BJ. Bone Marrow Pathology, 4th Edition. Wiley-Blackwell.
Mufti GJ, Estey EH, Stone RM. Myelodysplastic Syndromes: Optimizing Therapy. American Society of Clinical Oncology Educational Book. 2020;40:398-407.
Khoury JD, Solary E, Abla O, et al. The 5th edition of the WHO Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Cell Neoplasms. Leukemia. 2022;36(7):1703-1719.
Medication Comparisons
Compare medications used to treat Abnormal Granulocytopoietic Cell Morphology C4023031. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy